Theranostics is an escalating field within radiation oncology and clinicians should be utilizing it every day, according to Brandon Mancini, MD, MBA, FACRO.
ACRO Radiation Oncology Summit
J. Isabelle Choi, MD, outlined evidence-based strategies for radiation dose escalation in locoregionally advanced breast cancer.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
TLD-1433 Exhibits Early Efficacy in BCG-Unresponsive NMIBC CIS
2
Dato-DXd Receives Priority Review in Unresectable/Metastatic TNBC
3
FDA Accepts NDA for Rivoceranib and Camrelizumab in 1L Unresectable HCC
4
How Is the Immune System a “Critical Player” in NDMM Outcomes?
5